Chronic exposure to pro-inflammatory cytokines, TNF-α, IL-6, and insulin-growth-factor-binding proteins (IGFBPs) has been reported to induce insulin resistance by directly impairing insulin signaling activation while simultaneously fueling tumor activation [47,48]. The gene discussed is IL6; the disease is neoplasm.